300149 睿智医药
已收盘 12-24 15:00:00
资讯
新帖
简况
睿智医药收盘下跌6.73%，最新市净率2.58
金融界 · 12-23 17:35
睿智医药收盘下跌6.73%，最新市净率2.58
睿智医药12月16日现1笔大宗交易 成交金额201.85万元
新浪证券-红岸工作室 · 12-16
睿智医药12月16日现1笔大宗交易 成交金额201.85万元
12月16日睿智医药现1笔大宗交易 机构净买入201.85万元
证券之星 · 12-16
12月16日睿智医药现1笔大宗交易 机构净买入201.85万元
睿智医药(300149.SZ)拟向睿联投资定增募资不超9.31亿元 发行价为6.23元/股
智通财经 · 12-13
睿智医药(300149.SZ)拟向睿联投资定增募资不超9.31亿元 发行价为6.23元/股
睿智医药最新公告：拟向江门睿联医药投资有限公司发行不超过14938.92万股股票
证券之星 · 12-13
睿智医药最新公告：拟向江门睿联医药投资有限公司发行不超过14938.92万股股票
睿智医药最新公告：公司控制权拟变更
证券之星 · 12-13
睿智医药最新公告：公司控制权拟变更
12月9日睿智医药涨停分析：减肥药，创新药，医药概念热股
证券之星 · 12-09
12月9日睿智医药涨停分析：减肥药，创新药，医药概念热股
美生物安全法案“生变”，CRO概念大举反攻，药明系嗨了！
格隆汇 · 12-09
美生物安全法案“生变”，CRO概念大举反攻，药明系嗨了！
异动快报：睿智医药（300149）12月9日9点30分触及涨停板
证券之星 · 12-09
异动快报：睿智医药（300149）12月9日9点30分触及涨停板
A股CRO概念股拉升，睿智医药20CM涨停，迦南科技涨近15%，河化股份、德展健康涨停，药明康德涨近8%，药石科技、博济医药、百花医药跟涨。
美港电讯 · 12-09
A股CRO概念股拉升，睿智医药20CM涨停，迦南科技涨近15%，河化股份、德展健康涨停，药明康德涨近8%，药石科技、博济医药、百花医药跟涨。
A股CRO概念股开涨，德展健康涨停，睿智医药涨超13%，百花医药，药明康德、康龙化成、博腾股份、凯莱英等集体高开。
美港电讯 · 12-09
A股CRO概念股开涨，德展健康涨停，睿智医药涨超13%，百花医药，药明康德、康龙化成、博腾股份、凯莱英等集体高开。
睿智医药11月27日现1笔大宗交易 成交金额205.13万元
新浪证券-红岸工作室 · 11-27
睿智医药11月27日现1笔大宗交易 成交金额205.13万元
11月27日睿智医药现1笔大宗交易 机构净买入205.13万元
证券之星 · 11-27
11月27日睿智医药现1笔大宗交易 机构净买入205.13万元
睿智医药（300149）2024年三季报简析：净利润减96.88%
证券之星 · 10-31
睿智医药（300149）2024年三季报简析：净利润减96.88%
图解睿智医药三季报：第三季度单季净利润同比增107.64%
证券之星 · 10-30
图解睿智医药三季报：第三季度单季净利润同比增107.64%
睿智医药最新公告：签署战略合作框架协议
证券之星 · 09-30
睿智医药最新公告：签署战略合作框架协议
睿智医药(300149.SZ)与暨南大学生物活性分子与成药性优化全国重点实验室达成战略合作框架协议
智通财经 · 09-30
睿智医药(300149.SZ)与暨南大学生物活性分子与成药性优化全国重点实验室达成战略合作框架协议
A股CRO概念震荡走弱，睿智医药、河化股份跌超5%，万邦医药、百花医药、康龙化成、药明康德跟跌。
美港电讯 · 09-26
A股CRO概念震荡走弱，睿智医药、河化股份跌超5%，万邦医药、百花医药、康龙化成、药明康德跟跌。
睿智医药最新公告：目前公司正在与审计机构沟通关于以前年度报告更正事项
证券之星 · 09-25
睿智医药最新公告：目前公司正在与审计机构沟通关于以前年度报告更正事项
9月25日睿智医药（300149）龙虎榜数据：游资量化打板上榜
证券之星 · 09-25
9月25日睿智医药（300149）龙虎榜数据：游资量化打板上榜
加载更多
公司概况
公司名称：
睿智医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2010-12-22
主营业务：
睿智医药科技股份有限公司主营业务是为全球制药企业、生物技术公司以及科研院校提供药物发现、开发以及生产服务。医药研发及生产服务(CRO/CDMO)板块作为公司核心业务板块，按业务性质划分，医药研发及生产服务(CRO/CDMO)板块业务由化学类CRO,生物类CRO,小分子CDMO,大分子CDMO四大服务模块组成。公司微生态健康板块主要以生产低聚果糖,低聚半乳糖系列益生元产品为主。公司是国内极少数拥有临床前CRO（医药研发服务）及CMO（医药生产服务）全流程服务能力的领导品牌，在临床前CRO市场规模位于国内前三甲。
发行价格：
28.00
{"stockData":{"symbol":"300149","market":"SZ","secType":"STK","nameCN":"睿智医药","latestPrice":6.91,"timestamp":1735023810000,"preClose":7.07,"halted":0,"volume":19991193,"delay":0,"floatShares":497000000,"shares":498000000,"eps":-1.902,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.16,"latestTime":"12-24 15:00:00","open":7.1,"high":7.16,"low":6.7,"amount":137000000,"amplitude":0.0651,"askPrice":6.92,"askSize":326,"bidPrice":6.91,"bidSize":677,"shortable":0,"etf":0,"ttmEps":-1.902,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735090200000},"adr":0,"adjPreClose":7.07,"symbolType":"stock","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":7.78,"lowLimit":6.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":497963992,"pbRate":2.58,"roa":"--","roe":"--","epsLYR":-1.84,"committee":-0.328331,"marketValue":3441000000,"floatMarketCap":3435000000,"peRate":-3.633018,"changeRate":-0.0226,"turnoverRate":0.0402,"status":1},"requestUrl":"/m/hq/s/300149","defaultTab":"news","newsList":[{"id":"2493731871","title":"睿智医药收盘下跌6.73%，最新市净率2.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2493731871","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493731871?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:35","pubTimestamp":1734946541,"startTime":"0","endTime":"0","summary":"12月23日，睿智医药今日收盘7.07元，下跌6.73%，最新市净率2.58。资金流向方面，12月23日，睿智医药主力资金净流出1186.55万元，近5日总体呈流出状态，5日共流出4174.58万元。睿智医药科技股份有限公司主营业务是为全球制药企业、生物技术公司以及科研院校提供药物发现、开发以及生产服务。最新一期业绩显示，2024年三季报，公司实现营业收入7.19亿元，同比-15.09%；净利润-61667008.36元，同比-96.88%，销售毛利率19.22%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/23173546705679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","BK0216","300149"],"gpt_icon":0},{"id":"2491652761","title":"睿智医药12月16日现1笔大宗交易 成交金额201.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491652761","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491652761?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:00","pubTimestamp":1734339600,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 12月16日，睿智医药收涨4.43%，收盘价为8.01元，发生1笔大宗交易，合计成交量25.2万股，成交金额201.85万元。 第1笔成交价格为8.01元，成交25.20万股，成交金额201.85万元，溢价率为0.00%，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为406.98万元。该股近5个交易日累计下跌5.76%，主力资金合计净流出1.4亿元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-16/doc-inczrzsr2546093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","300149","BK0077"],"gpt_icon":0},{"id":"2491865452","title":"12月16日睿智医药现1笔大宗交易 机构净买入201.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491865452","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491865452?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:48","pubTimestamp":1734338903,"startTime":"0","endTime":"0","summary":"证券之星消息，12月16日睿智医药发生大宗交易，交易数据如下：大宗交易成交价格8.01元，成交25.2万股，成交金额201.85万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生2笔大宗交易，合计成交5600.0手。该股近期无解禁股上市。截至2024年12月16日收盘，睿智医药(300149)报收于8.01元，上涨4.43%，换手率12.26%，成交量60.95万手，成交额4.99亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600021307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"gpt_icon":0},{"id":"2491375750","title":"睿智医药(300149.SZ)拟向睿联投资定增募资不超9.31亿元 发行价为6.23元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491375750","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491375750?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:42","pubTimestamp":1734100962,"startTime":"0","endTime":"0","summary":"智通财经APP讯，睿智医药(300149.SZ)披露2024年度向特定对象发行股票预案，公司拟向睿联投资(拟设立)发行股票。本次向特定对象发行股票的发行价格为6.23元/股，数量不超过1.49亿股(含本数)。睿联投资(拟设立)的实际控制人WOO SWEE LIAN先生为上市公司董事长、首席执行官(CEO)，且本次发行后睿联投资(拟设立)将成为上市公司的控股股东，WOO SWEE LIAN先生为上市公司实际控制人。据悉，本次向特定对象发行股票预计募集资金总额不超过9.31亿元(含本数)，扣除发行费用后的募集资金净额将全部用于补充流动资金、偿还银行借款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300149","BK0077","BK0216"],"gpt_icon":0},{"id":"2491468373","title":"睿智医药最新公告：拟向江门睿联医药投资有限公司发行不超过14938.92万股股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2491468373","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491468373?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:19","pubTimestamp":1734099598,"startTime":"0","endTime":"0","summary":"睿智医药公告，拟通过定向发行股票的方式向江门睿联医药投资有限公司发行不超过14938.92万股人民币普通股股票，不超过本次发行前公司总股本的30%。发行价格为6.23元/股，最终认购金额为根据协议确定的认购数量乘以发行价格所得的数值。认购人用于认购本次发行股票的资金为其自筹合法资金（含自有资金、借贷资金等）。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300047235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK1515","BK0216","BK1161","159938","09939","300149","BK1574"],"gpt_icon":0},{"id":"2491373431","title":"睿智医药最新公告：公司控制权拟变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2491373431","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491373431?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:19","pubTimestamp":1734099576,"startTime":"0","endTime":"0","summary":"睿智医药公告称，根据广东省江门市中级人民法院出具的《民事调解书》，上市公司股东北海八本创业投资有限公司同意向WOO SWEE LIAN过户转让其所持公司30,033,098股股份，转让价格按调解书生效前一日收盘价的80%计算。发行完成后，睿联投资将持有公司149,389,197股股份，持股比例为23.08%，成为公司控股股东，WOO SWEE LIAN合计持有公司股份数将上升至227,582,592股，持股比例为35.16%，仍为公司实际控制人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300047234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"gpt_icon":0},{"id":"2490971163","title":"12月9日睿智医药涨停分析：减肥药，创新药，医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490971163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490971163?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:13","pubTimestamp":1733728416,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药12月9日涨停收盘，收盘价8.5元。该股于9点30分涨停，未打开涨停，截止收盘封单资金为8311.69万元，占其流通市值1.97%。12月9日的资金流向数据方面，主力资金净流入7046.64万元，占总成交额24.93%，游资资金净流出4222.11万元，占总成交额14.94%，散户资金净流出2824.53万元，占总成交额9.99%。近5日资金流向一览见下表：该股为减肥药，创新药，医药概念热股，当日减肥药概念上涨1.61%，创新药概念上涨0.67%，医药概念上涨0.55%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900013442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","06978","BK1574","BK0077","09939","BK1161","BK0216","BK1515","300149","159938"],"gpt_icon":0},{"id":"2490718823","title":"美生物安全法案“生变”，CRO概念大举反攻，药明系嗨了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2490718823","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490718823?lang=zh_cn&edition=full","pubTime":"2024-12-09 12:10","pubTimestamp":1733717419,"startTime":"0","endTime":"0","summary":"行业悲观预期或好转","market":"hk","thumbnail":"https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1449943","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1521","LU0516422366.SGD","603259","LU0456842615.SGD","LU1997245177.USD","BK0042","NDAA","LU1688375341.USD","LU0043850808.USD","LU0359201612.USD","LU0307460666.USD","LU0819121731.USD","02359","02268","BK0077","301201","BK0081","LU0456846285.SGD","LU0823426308.USD","LU0572944931.SGD","LU2488822045.USD","LU0823426480.USD","LU0327786744.USD","300149","BK1576","LU1880383366.USD","LU2045819591.USD","BK1583","LU0856984785.SGD","000710","LU0320764599.SGD","LU0348825331.USD","LU1794554557.SGD","BK1141","LU0052750758.USD","LU2039709279.SGD","BK0216","LU0051755006.USD","BK0028","BK0102","SG9999014674.SGD","LU0348735423.USD","LU1242518931.SGD","LU0359202008.SGD","LU0456827905.SGD","SG9999002562.SGD","LU2242644610.SGD","BK0086","LU1046422090.SGD"],"gpt_icon":1},{"id":"2490760636","title":"异动快报：睿智医药（300149）12月9日9点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2490760636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490760636?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:36","pubTimestamp":1733708200,"startTime":"0","endTime":"0","summary":"证券之星12月9日盘中消息，9点30分睿智医药（300149）触及涨停板。目前价格8.5，上涨20.06%。其所属行业医疗服务目前上涨。领涨股为博腾股份。该股为创新药，减肥药，医药概念热股，当日创新药概念上涨2.01%，减肥药概念上涨1.89%，医药概念上涨1.48%。12月6日的资金流向数据方面，主力资金净流出1203.24万元，占总成交额10.26%，游资资金净流入615.97万元，占总成交额5.25%，散户资金净流入587.27万元，占总成交额5.01%。近5日资金流向一览见下表：睿智医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900003472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"gpt_icon":0},{"id":"2490876245","title":"A股CRO概念股拉升，睿智医药20CM涨停，迦南科技涨近15%，河化股份、德展健康涨停，药明康德涨近8%，药石科技、博济医药、百花医药跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2490876245","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490876245?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:33","pubTimestamp":1733707995,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2045819591.USD","300412","603259","LU0708995583.HKD","BK0071","BK0010","BK0028","BK0077","BK0132","159982","BK1576","BK0239","000953","BK0229","LU1046422090.SGD","600721","BK0066","300725","02359","BK0004","LU0456842615.SGD","LU2242644610.SGD","BK0216","300149","LU2488822045.USD","BK0060","LU0320764599.SGD","LU0052750758.USD","000813","LU1997245094.SGD","BK1141","BK0114","BK0102","BK1583","BK0251","300404","LU2125910500.SGD","399300","LU1997245177.USD"],"gpt_icon":0},{"id":"2490762688","title":"A股CRO概念股开涨，德展健康涨停，睿智医药涨超13%，百花医药，药明康德、康龙化成、博腾股份、凯莱英等集体高开。","url":"https://stock-news.laohu8.com/highlight/detail?id=2490762688","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490762688?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:27","pubTimestamp":1733707637,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2045819591.USD","603259","LU0708995583.HKD","BK1576","BK0077","BK0028","BK0132","159982","BK0239","002821","LU1046422090.SGD","600721","03759","02359","300759","BK1191","LU0456842615.SGD","LU2242644610.SGD","300363","BK0216","06821","300149","LU2488822045.USD","LU1328615791.USD","BK0060","LU0320764599.SGD","LU0052750758.USD","000813","LU1997245094.SGD","BK1141","BK0114","BK0102","BK1583","LU2125910500.SGD","399300","LU1997245177.USD"],"gpt_icon":0},{"id":"2486848484","title":"睿智医药11月27日现1笔大宗交易 成交金额205.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486848484","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486848484?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:00","pubTimestamp":1732698000,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 11月27日，睿智医药收涨0.45%，收盘价为6.66元，发生1笔大宗交易，合计成交量30.8万股，成交金额205.13万元。 第1笔成交价格为6.66元，成交30.80万股，成交金额205.13万元，溢价率为0.00%，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为205.13万元。该股近5个交易日累计下跌2.92%，主力资金合计净流出958.07万元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-27/doc-incxnwik6796376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300149","BK0077","BK0216"],"gpt_icon":0},{"id":"2486810461","title":"11月27日睿智医药现1笔大宗交易 机构净买入205.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486810461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486810461?lang=zh_cn&edition=full","pubTime":"2024-11-27 16:52","pubTimestamp":1732697546,"startTime":"0","endTime":"0","summary":"证券之星消息，11月27日睿智医药发生大宗交易，交易数据如下：大宗交易成交价格6.66元，成交30.8万股，成交金额205.13万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生1笔大宗交易，合计成交3080.0手。该股近期无解禁股上市。截至2024年11月27日收盘，睿智医药(300149)报收于6.66元，上涨0.45%，换手率1.76%，成交量8.75万手，成交额5725.09万元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700027261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"gpt_icon":0},{"id":"2479760011","title":"睿智医药（300149）2024年三季报简析：净利润减96.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479760011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479760011?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:39","pubTimestamp":1730327971,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期睿智医药发布2024年三季报。根据财报显示，睿智医药净利润减96.88%。截至本报告期末，公司营业总收入7.19亿元，同比下降15.09%，归母净利润-6166.7万元，同比下降96.88%。按单季度数据看，第三季度营业总收入2.53亿元，同比下降12.25%，第三季度归母净利润123.95万元，同比上升107.64%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149"],"gpt_icon":0},{"id":"2479370302","title":"图解睿智医药三季报：第三季度单季净利润同比增107.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479370302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479370302?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:57","pubTimestamp":1730224673,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药2024年三季报显示，公司主营收入7.19亿元，同比下降15.09%；归母净利润-6166.7万元，同比下降96.88%；扣非净利润-6904.13万元，同比下降78.07%；其中2024年第三季度，公司单季度主营收入2.53亿元，同比下降12.25%；单季度归母净利润123.95万元，同比上升107.64%；单季度扣非净利润-500.27万元，同比上升69.81%；负债率35.56%，投资收益730.2万元，财务费用810.55万元，毛利率19.22%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000001601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149"],"gpt_icon":0},{"id":"2471805564","title":"睿智医药最新公告：签署战略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2471805564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471805564?lang=zh_cn&edition=full","pubTime":"2024-09-30 19:17","pubTimestamp":1727695032,"startTime":"0","endTime":"0","summary":"睿智医药公告，公司与暨南大学生物活性分子与成药性优化全国重点实验室签署了《战略合作框架协议》。双方以“协同创新、合作共赢”为合作理念，致力于建立产学研高度融合的创新合作体系。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000034840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"gpt_icon":0},{"id":"2471873163","title":"睿智医药(300149.SZ)与暨南大学生物活性分子与成药性优化全国重点实验室达成战略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2471873163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471873163?lang=zh_cn&edition=full","pubTime":"2024-09-30 16:47","pubTimestamp":1727686066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，睿智医药(300149.SZ)公告，公司近日与暨南大学生物活性分子与成药性优化全国重点实验室(简称“暨南大学全国重点实验室”)签署了《战略合作框架协议》。双方以“协同创新、合作共赢”为合作理念，致力于建立产学研高度融合的创新合作体系。充分利用公司专业的新药研发服务能力，推动暨南大学全国重点实验室创新药成果的验证和转化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300149","BK0216","BK0077"],"gpt_icon":0},{"id":"2470247675","title":"A股CRO概念震荡走弱，睿智医药、河化股份跌超5%，万邦医药、百花医药、康龙化成、药明康德跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2470247675","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470247675?lang=zh_cn&edition=full","pubTime":"2024-09-26 09:44","pubTimestamp":1727315052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0066","LU1997245177.USD","399300","159982","000953","LU0052750758.USD","LU1997245094.SGD","LU1046422090.SGD","LU0320764599.SGD","BK0010","BK1576","LU0456842615.SGD","LU2242644610.SGD","BK0102","300149","BK0004","LU0708995583.HKD","02359","LU2488822045.USD","BK1583","301520","LU2125910500.SGD","LU2045819591.USD","600721","BK0216","BK0071","BK0077","603259","03759","BK0239","BK1141","300759"],"gpt_icon":0},{"id":"2470323915","title":"睿智医药最新公告：目前公司正在与审计机构沟通关于以前年度报告更正事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2470323915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470323915?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:50","pubTimestamp":1727257814,"startTime":"0","endTime":"0","summary":"目前公司正在与审计机构沟通关于以前年度报告更正事项，具体准确的财务数据请以公司后续披露的更正后的相关报告为准。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092500028433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"gpt_icon":0},{"id":"2470235961","title":"9月25日睿智医药（300149）龙虎榜数据：游资量化打板上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2470235961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470235961?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:12","pubTimestamp":1727255568,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年9月25日公布的交易公开信息显示，睿智医药因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2024年9月25日收盘，睿智医药报收于6.09元，上涨12.99%，换手率18.2%，成交量90.82万手，成交额5.24亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入207.61万元。量化打板等知名游资榜上有名。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092500027242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-12-22","address":"广东省江门市江海区胜利南路164号","stockEarnings":[{"period":"1week","weight":-0.0662},{"period":"1month","weight":0.0438},{"period":"3month","weight":0.1346},{"period":"6month","weight":0.7062},{"period":"1year","weight":-0.0896},{"period":"ytd","weight":-0.0967}],"companyName":"睿智医药科技股份有限公司","boardCode":"AI0073","perCapita":"15173股","boardName":"研究和试验发展","registeredCapital":"49796万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0387},{"period":"3month","weight":0.1717},{"period":"6month","weight":0.152},{"period":"1year","weight":0.1626},{"period":"ytd","weight":0.1407}],"survey":" 睿智医药科技股份有限公司主营业务是为全球制药企业、生物技术公司以及科研院校提供药物发现、开发以及生产服务。医药研发及生产服务(CRO/CDMO)板块作为公司核心业务板块，按业务性质划分，医药研发及生产服务(CRO/CDMO)板块业务由化学类CRO,生物类CRO,小分子CDMO,大分子CDMO四大服务模块组成。公司微生态健康板块主要以生产低聚果糖,低聚半乳糖系列益生元产品为主。公司是国内极少数拥有临床前CRO（医药研发服务）及CMO（医药生产服务）全流程服务能力的领导品牌，在临床前CRO市场规模位于国内前三甲。","serverTime":1735066965633,"listedPrice":28,"stockholders":"32760人(较上一季度增加13.88%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿智医药,300149,睿智医药股票,睿智医药股票老虎,睿智医药股票老虎国际,睿智医药行情,睿智医药股票行情,睿智医药股价,睿智医药股市,睿智医药股票价格,睿智医药股票交易,睿智医药股票购买,睿智医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}